GLAXOSMITHKLINE PLC

GSK
Real-time Estimate Quote. Real-time Estimate  - 08/07 11:30:00 am
1554.1GBX +0.26%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (52%): intended for respiratory diseases (67.5% of net sales), HIV infection (27.7%), immune system disorders (3.5%) ) and cancer (1,3%);
- OTC and parapharmaceutical medicine (26.7%);
- vaccines (21.2%);
- other (0.1%).
Net sales are distributed geographically as follows: the United Kingdom (2.8%), the United States (41.1%) and other (56.1%).

Number of employees : 99 437 people.
Sales per Business
20182019
GBP
(in Million)
%GBP
(in Million)
%
Pharmaceuticals 17,26956% 17,55452%
Consumer Healthcare 7,65824.8% 8,99526.6%
Vaccines 5,89419.1% 7,15721.2%
Corporate and Other Unallocated -- 48.000.1%
Sales per region
20182019
GBP
(in Million)
%GBP
(in Million)
%
United States 11,98238.9% 13,89041.2%
International 10,86635.3% 11,79534.9%
Europe 7,05022.9% 7,12721.1%
United Kingdom 923.003% 942.002.8%
Managers
Name Title
Emma N. Walmsley Chief Executive Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Iain James Mackay Chief Financial Officer & Executive Director
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Jon Ellis Vice President & Head-Science & Technology
Judy Carol Lewent Independent Non-Executive Director
Lynn Laverty Elsenhans Independent Non-Executive Director
Urs Rohner Independent Non-Executive Director
Manvinder Singh Banga Senior Independent Non-Executive Director
Shareholders
Name Equities %
The Vanguard Group, Inc. 156,389,000 3.12%
BlackRock Investment Management (UK) Ltd. 128,982,522 2.57%
BlackRock Fund Advisors 125,845,762 2.51%
Norges Bank Investment Management 121,210,000 2.42%
Legal & General Investment Management Ltd. 103,396,438 2.06%
Threadneedle Asset Management Ltd. 64,576,011 1.29%
State Street Global Advisors Ltd. 61,697,547 1.23%
Dodge & Cox 61,624,000 1.23%
BlackRock Advisors (UK) Ltd. 61,504,607 1.23%
Schroder Investment Management Ltd. 57,239,476 1.14%
Company contact information
980 Great West Road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC-12.81%101 272
JOHNSON & JOHNSON1.73%388 473
ROCHE HOLDING AG0.33%295 798
PFIZER, INC.-2.32%212 583
MERCK & CO., INC.-10.89%204 995
NOVARTIS AG-17.29%183 979
ABBVIE INC.4.55%163 371
NOVO NORDISK A/S3.56%148 339
ASTRAZENECA PLC10.67%145 041
AMGEN INC.0.20%141 474
BRISTOL-MYERS SQUIBB COMPANY-4.46%138 771
ELI LILLY AND COMPANY16.32%138 581
SANOFI-3.59%128 581
GLAXOSMITHKLINE PLC-12.87%101 272
CHUGAI PHARMACEUTICAL CO., LTD.43.57%75 774
JIANGSU HENGRUI MEDICINE CO., LTD.25.05%69 157
BAYER AG-23.18%65 088
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED-12.12%57 137
DAIICHI SANKYO COMPANY, LIMITED29.00%56 561
ASTELLAS PHARMA INC.-11.58%29 232
Brand Portfolio
GLAXOSMITHKLINE
GLAXOSMITHKLINE
GSK
GSK
CELLZOME
CELLZOME
CORIXA
CORIXA
DOMANTIS
DOMANTIS
GENELABS TECHNOLOGIES
GENELABS TECHNOLOGIES
GLYCOVAXYN
GLYCOVAXYN
STIEFEL
STIEFEL
TESARO
TESARO
More brands of GlaxoSmithKline Plc